优化诱导β共同受体增强促红细胞生成素在脊髓缺血性损伤中的神经保护功能
该研究在小鼠脊髓缺血再灌注模型中,用二氮嗪(DZ)上调促红细胞生成素受体β共同亚基(βcR)表达,再联合促红细胞生成素(EPO)治疗。结果显示DZ+EPO组48小时运动功能保留显著优于其他各组,DZ单用和EPO单用组也显著优于对照组。
要点
- DZ诱导βcR表达的最佳时间为给药后36小时,最佳剂量为20 mg/kg。
- 脊髓缺血再灌注后48小时,DZ+EPO组运动功能显著优于其他所有组。
- DZ单用组和EPO单用组运动功能均显著优于对照组(PBS+PBS)。
核心结论
- 用DZ药物上调βcR可增强EPO预防脊髓缺血再灌注损伤的疗效。
- 更好地理解这一协同机制可能有助于进一步预防高风险主动脉干预的缺血并发症。
研究设计与样本
- 研究为动物实验,使用成年雄性C57/BL6小鼠。
- DZ时间试验:小鼠口服灌胃DZ 20 mg/kg,于给药后0、12、24、36、48小时取脊髓。
- 剂量优化试验:DZ给药剂量为0、5、10、20、40 mg/kg。
- 用蛋白质印迹法评估βcR表达。
- 研究分五组:PBS(预处理)+PBS(紧邻术前)、PBS+EPO、DZ+PBS、DZ+EPO和假手术组(不夹闭主动脉)。
主要发现
- 蛋白质印迹分析显示,DZ给药后36小时βcR上调最佳,βcR诱导的最佳DZ剂量为20 mg/kg。
- 治疗后48小时,DZ+EPO组运动功能保留显著优于所有其他组。
- DZ单用组和EPO单用组运动功能保留均显著优于对照组(PBS+PBS)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paraplegia remains the most feared complication of complex thoracoabdominal aortic intervention. Although erythropoietin (EPO) has demonstrated neuroprotective effects in spinal cord ischemia, it does not work until expression of the beta common receptor subunit of the EPO receptor (βcR) is induced by ischemia. We hypothesized that the βcR can be induced by diazoxide (DZ), amplifying the neuroprotective effects of EPO in spinal cord ischemia-reperfusion injury. METHODS: For the DZ time trial, adult male C57/BL6 mice received DZ (20 mg/kg) by oral gavage. Spinal cords were harvested after 0, 12, 24, 36, and 48 hours of administration. To evaluate optimal dosing, DZ was administered at 0, 5, 10, 20, and 40 mg/kg. The expression of βcR was assessed by Western blot analysis. Five groups were studied: PBS (pretreatment)+PBS (immediately before), PBS+EPO, DZ+PBS, DZ+EPO, and sham (without cross-clamping). Spinal cord ischemia was induced by 4 minutes of thoracic aortic cross-clamping. Functional scoring (Basso Mouse Score) was done at 12-hour intervals for 48 hours, and spinal cords were harvested for histological analysis. RESULTS: Western blot analysis demonstrated that optimal βcR up-regulation occurred at 36 hours after DZ administration, and the optimal DZ dosage for βcR induction was 20 mg/kg. Motor function at 48 hours after treatment was significantly better preserved in the DZ+EPO group compared with all other groups, and was significantly better preserved in the DZ only and EPO only groups compared with control (PBS+PBS). CONCLUSIONS: Pharmacologic up-regulation of βcR with DZ can increase the efficacy of EPO in preventing spinal cord ischemia and reperfusion injury. Improved understanding of this synergetic mechanism may serve to further prevent ischemic complications for high-risk aortic intervention.
引用
- Yamanaka K, Eldeiry M, Aftab M, et al. Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury. J Thorac Cardiovasc Surg. 2018. PMID: 29523405. doi:10.1016/j.jtcvs.2017.12.132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。